Galantamine Hydrobromide Extended Release: Clinical Trials

1 trial of Galantamine Hydrobromide Extended Release, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Galantamine Hydrobromide Extended Release: new trials by email Literature Review of Galantamine Hydrobromide Extended Release trials Research Report on Galantamine Hydrobromide Extended Release

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Galantamine Hydrobromide Extended Release - Spinal Cord Injury, Traumatic Spinal Cord Injury
Phase 2 / Phase 3RecruitingNorthwell Health602026-10-152026-11-04

Conditions studied

Metabolic Syndrome (1)  ·  Paraplegia (1)  ·  Quadriplegia (1)  ·  Spinal Cord Injuries (1)

Sponsors

Northwell Health (1)

Countries

United States (1)